NVS - Novartis AG - ADR
Close
120.89
0.470 0.389%
Share volume: 902,626
Last Updated: Fri 30 Aug 2024 10:00:02 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$120.42
0.47
0.39%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-10-25 | 2023-02-01 | 2023-04-25 | 2023-07-18 | 2023-10-24 | 2024-01-31 | 2024-04-23 | 2024-07-18 | |
| Assets | |||||||||
| Total Assets | 118.464 B | 117.453 B | 112.241 B | 110.979 B | 112.697 B | 99.945 B | 94.334 B | 97.505 B | |
| Current Assets | 36.954 B | 36.910 B | 32.114 B | 33.493 B | 45.660 B | 30.481 B | 26.447 B | 25.693 B | |
| Inventories | 6.779 B | 7.175 B | 7.886 B | 8.228 B | 5.610 B | 5.913 B | 5.743 B | 5.747 B | |
| Other Current Assets | 2.392 B | 1.869 B | 2.785 B | 2.828 B | 2.782 B | 2.016 B | 2.759 B | 3.031 B | |
| Short Term Investments | 2.392 B | 1.869 B | 2.785 B | 2.828 B | 2.782 B | 2.016 B | 2.759 B | 3.031 B | |
| Total Receivables | 8.680 B | 8.893 B | 9.183 B | 9.543 B | 7.099 B | 8.124 B | 8.251 B | 8.480 B | |
| Current Cash | 19.103 B | 18.973 B | 12.260 B | 11.174 B | 12.695 B | 14.428 B | 9.694 B | 8.435 B | |
| Total Non-current Assets | 81.510 B | 80.543 B | 80.127 B | 77.486 B | 67.037 B | 69.464 B | 67.887 B | 71.812 B | |
| Property Plant Equipment | 10.315 B | 10.764 B | 10.841 B | 10.825 B | 9.044 B | 9.514 B | 9.200 B | 9.254 B | |
| Other Assets | 6.547 B | 3.070 B | 5.143 B | 4.966 B | 4.329 B | 3.155 B | 5.038 B | 5.046 B | |
| Intangible Assets | 31.888 B | 31.644 B | 30.451 B | 28.003 B | 26.418 B | 26.879 B | 26.272 B | 27.775 B | |
| Goodwill | 28.668 B | 29.301 B | 29.481 B | 29.522 B | 23.416 B | 23.341 B | 23.063 B | 25.234 B | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 118.464 B | 117.453 B | 112.241 B | 110.979 B | 112.697 B | 99.945 B | 94.334 B | 97.505 B | |
| Total liabilities | 57.644 B | 58.111 B | 60.182 B | 59.132 B | 74.533 B | 53.278 B | 54.659 B | 55.772 B | |
| Total current liabilities | 28.160 B | 28.656 B | 30.549 B | 31.909 B | 48.393 B | 26.390 B | 29.288 B | 27.612 B | |
| Accounts Payable | 4.693 B | 5.146 B | 5.426 B | 5.350 B | 3.870 B | 4.926 B | 4.062 B | 4.146 B | |
| Other liabilities | 5.452 B | 4.906 B | 4.838 B | 4.809 B | 4.081 B | 4.523 B | 4.259 B | 4.312 B | |
| Current long term debt | 7.303 B | 6.127 B | 7.219 B | 8.536 B | 19.630 B | 6.314 B | 8.564 B | 7.764 B | |
| Long term debt | 21.235 B | 21.782 B | 21.985 B | 19.804 B | 19.521 B | 20.034 B | 18.720 B | 21.223 B | |
| Other liabilities | 5.452 B | 4.906 B | 4.838 B | 4.809 B | 4.081 B | 4.523 B | 4.259 B | 4.312 B | |
| Minority interest | 78.000 M | 81.000 M | 83.000 M | 84.000 M | 81.000 M | 83.000 M | 81.000 M | 169.000 M | |
| Total Shareholder equity | 60.820 B | 59.342 B | 52.059 B | 51.847 B | 38.164 B | 46.667 B | 39.675 B | 41.733 B | |
| Common stock | 2.167 B | 2.134 B | 2.110 B | 2.083 B | 2.062 B | 2.053 B | 2.044 B | 2.033 B | |
| Retained earnings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 |